Insider Transactions in Q2 2024 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2024
|
Robert B Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+50.0%
|
-
|
|
May 16
2024
|
Timothy L Main Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+5.58%
|
-
|
|
May 16
2024
|
Timothy M Ring Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+5.06%
|
-
|
|
May 16
2024
|
Gary M Pfeiffer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+4.88%
|
-
|
|
May 16
2024
|
Tracey Doi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+22.24%
|
-
|
|
May 16
2024
|
Denise M Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+13.51%
|
-
|
|
May 16
2024
|
Wright Lassiter Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+16.12%
|
-
|
|
May 16
2024
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+7.65%
|
-
|
|
May 16
2024
|
Luis Diaz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+34.2%
|
-
|
|
Apr 29
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct |
1,760
-11.58%
|
$246,400
$140.0 P/Share
|
|
Apr 22
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
45
+0.3%
|
$5,670
$126.25 P/Share
|
|
Apr 22
2024
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.49%
|
$10,206
$126.24 P/Share
|
|
Apr 22
2024
|
Sam Samad Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.11%
|
$3,024
$126.25 P/Share
|
|
Apr 22
2024
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Grant, award, or other acquisition
|
Direct |
69
+0.43%
|
$8,694
$126.25 P/Share
|